Bibliografía
1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA. Cancer J. Clin. 2019;69:7–34.
2. Amri R, Bordeianou LG, Berger DL. Effect of High-Grade Disease on Outcomes of Surgically Treated Colon Cancer. Ann. Surg. Oncol. 2016;23:1157–63.
3. Kang GH. Four molecular subtypes of colorectal cancer and their precursor lesions. Arch. Pathol. Lab. Med. 2011;135:698–703.
4. A Cienfuegos J, Baixauli J, Arredondo J, et al. Clinico-pathological and oncological differences between right and left-sided colon cancer (stages I-III): analysis of 950 cases. Rev. Esp. Enferm. Dig. 2018;110:138–144.
5. Gill S, Loprinzi CL, Sargent DJ, et al. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? J. Clin. Oncol. 2004;22:1797–1806.
6. Benson 3rd AB, Schrag D, Somerfield MR, et al. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J. Clin. Oncol. 2004;22:3408–3419.
7. Liska D, Stocchi L, Karagkounis G, et al. Incidence, patterns, and predictors of locoregional recurrence in colon cancer. Ann. Surg. Oncol. 2017;24:1093–1099.
8. Lavery IC, De Campos-Lobato LF. How to evaluate risk and identify stage II patients requiring referral to a medical oncologist: a surgeon’s perspective. Oncology (Williston Park). 2010;24:14–6..
9. Shia J, Wang H, Nash GM, et al. Lymph node staging in colorectal cancer: revisiting the benchmark of at least 12 lymph nodes in R0 resection. J. Am. Coll. Surg. 2012;214:348–355.
10. Chang GJ, Rodriguez-Bigas MA, Skibber JM, et al. Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J. Natl. Cancer Inst. 2007;99:433–441.
11. Skancke M, Arnott SM, Amdur RL, et al. Lymphovascular invasion and perineural invasion negatively impact overall survival for stage II adenocarcinoma of the colon. Dis. Colon Rectum 2019;62:181–188.
12. Alotaibi AM, Lee JL, Kim J, et al. Prognostic and Oncologic Significance of Perineural Invasion in Sporadic Colorectal Cancer. Ann. Surg. Oncol. 2017;24:1626–1634.
13. Compton CC, Byrd DR, Garcia-Aguilar J, et al. AJCC Cancer Staging Atlas. 2 2013. New York, NY: Springer New York; 2012.
14. Chang GJ, Kaiser AM, Mills S,et al. Practice parameters for the management of colon cancer. Dis. Colon Rectum 2012;55:831–843.
15. Washington MK, Berlin J, Branton P, et al. Protocol for the examination of specimens from patients with primary carcinoma of the colon and rectum. Arch. Pathol. Lab. Med. 2009;133:1539–1551.
16. Hamilton SR, Bosman FT, Boffetta P, et al. Carcinoma of the colon and rectum. In: FT B, Carneiro F, Hruban R, ND T, editors. WHO classification of tumours of the digestive system.Vol 4th. Lyon: International Agency for Research on Cancer, 2010:134–146.
17. Batsakis JG. Nerves and neurotropic carcinomas. Ann. Otol. Rhinol. Laryngol. 1985;94:426–427.
18. Sato T, Ueno H, Mochizuki H, et al. Objective criteria for the grading of venous invasion in colorectal cancer. Am. J. Surg. Pathol. 2010;34:454–462.
19. Andre T, Sargent D, Tabernero J, et al. Current issues in adjuvant treatment of stage II colon cancer. Ann. Surg. Oncol. 2006;13:887–898.
20. Benson AB, Venook AP, Cederquist L, et al. Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology. J. Natl. Compr. Canc. Netw. 2017;15:370–398
21. Budde CN, Tsikitis VL, Deveney KE, et al. Increasing the number of lymph nodes examined after colectomy does not improve colon cancer staging. J. Am. Coll. Surg. 2014;218:1004–11..
22. Cienfuegos JA, Martínez P, Baixauli J, et al. Perineural invasion is a major prognostic and predictive factor of response to adjuvant chemotherapy in stage I-II colon cancer. Ann. Surg. Oncol. 2016;24:1077–1084..
23. Swanson RS, Compton CC, Stewart AK, et al. The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann. Surg. Oncol. 2003;10:65–71.
24. Namm J, Ng M, Roy-Chowdhury S, et al. Quantitating the impact of stage migration on staging accuracy in colorectal cancer. J. Am. Coll. Surg. 2008;207:882–7..
25. Jass JR, Love SB, Northover JM. A new prognostic classification of rectal cancer. Lancet (London, England) 1987;1:1303–1306.
26. Märkl B, Wieberneit J, Kretsinger H, et al. Number of Intratumoral T Lymphocytes Is Associated With Lymph Node Size, Lymph Node Harvest, and Outcome in Node-Negative Colon Cancer. Am. J. Clin. Pathol. 2016;145:826–36
27. Galon J, Costes A, Sanchez-Cabo F, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006;313:1960–4.
28. Fridman WH, Pages F, Sautes-Fridman C,et al. The immune contexture in human tumours: impact on clinical outcome. Nat. Rev. 2012;12:298–306.
29. Pagès F, Mlecnik B, Marliot F, et al. International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study. Lancet 2018;391:2128–2139.
30. Moore J, Hyman N, Callas P, et al. Staging error does not explain the relationship between the number of lymph nodes in a colon cancer specimen and survival. Surgery 2010;147:358–65..
31. Pereira ER, Kedrin D, Seano G, et al. Lymph node metastases can invade local blood vessels, exit the node, and colonize distant organs in mice. Science 2018;359:1403–1407.
32. Brown M, Assen FP, Leithner A, et al. Lymph node blood vessels provide exit routes for metastatic tumor cell dissemination in mice. Science 2018;359:1408–1411..
33. Evans MD, Barton K, Rees A, et al.. The impact of surgeon and pathologist on lymph node retrieval in colorectal cancer and its impact on survival for patients with Dukes’ stage B disease. Colorectal Dis. 2008;10:157–64.